A paper now published in JCI Insight by CITF-funded researchers Drs. Anne-Claude Gingras, Tania Watts, and Vinod Chandran of the University of Toronto provides evidence of the need for a third dose of mRNA vaccine in patients with immune-mediated inflammatory diseases (IMID).